BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer.
Sci Rep
; 5: 17499, 2015 Dec 07.
Article
in En
| MEDLINE
| ID: mdl-26639561
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Proto-Oncogene Proteins
/
Carcinoma, Non-Small-Cell Lung
/
Apoptosis Regulatory Proteins
/
TOR Serine-Threonine Kinases
/
ErbB Receptors
/
Erlotinib Hydrochloride
/
Lung Neoplasms
/
Membrane Proteins
/
Mutation
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Sci Rep
Year:
2015
Document type:
Article
Affiliation country:
Spain